FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1128-1129 October 11, 2001 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Sargent, D. J.

More than half of all new cancers in the United States occur in patients 65 years of age or older.¹ The incidence of cancer in this age group is 11 times that in the population under 65 (2261 per 100,000 population, as compared with 207 per 100,000 population), and more than half of all deaths due to cancer occur in patients 65 or older. This age group accounts for two thirds to three fourths of colorectal cancers and at least three fourths of deaths from colorectal cancer. The increasing longevity of our population makes these statistics especially sobering; by 2030 . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Trimble, E. L., Christian, M. C. (2006). Cancer treatment and the older patient.. Clin. Cancer Res. 12: 1956-1957 [Full Text]  
• Talarico, L., Chen, G., Pazdur, R. (2004). Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug Administration. JCO 22: 4626-4631 [Abstract] [Full Text]  
• Bowcock, S. J, Shee, C. D, Rassam, S. M B, Harper, P. G (2004). Chemotherapy for cancer patients who present late. BMJ 328: 1430-1432 [Full Text]  
• Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., Escarce, J. J. (2003). Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials. JCO 21: 1383-1389 [Abstract] [Full Text]